socaltech | Shared With: Everyone - Oct 06 2006 | cabrellis, vp, regulatory, affairs, novartis, cancer, vice, president, socaltechSan Diego-based Cabrellis Pharmaceuticals has named a new Vice President of Regulatory Affairs and Development Operations. Cabrellis said earlier this week that Tracy Lawhon has been appointed to the position, joining the firm from Novartis Pharmaceutical
socaltech | Shared With: Everyone - Aug 08 2006 | cabrellis, cancer, lung, domain, associates, venture, capital, vc, investment, funding, anthracycline, socaltechSan Diego-based Cabrellis Pharmaceuticals, which is developing treatments for cancer, said Monday that it has raised $27.5M in a Series A funding round. Funding came from Domain Associates, Forward Ventures, Lilly Ventures, Novo A/S, ProQuest Investments,
Related Content from Around Faves
socaltech
- 1 FaverViewed: 5 Times
- socaltech - Aug 17 20061 FaverViewed: 7 Times
- socaltech - Oct 06 20061 FaverViewed: 3 Times
cancer
-
More and more people are turning to alternate therapies today. Whereas, integrated therapies combine mainstream medical treatments with complementary or alternative therapies, for which some high-quality scientific evidence of safety and efficacy now e...
14 Favers - ClaraSet - yesterday7 Favers
- ClaraSet - 2 days ago4 Favers
